ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
135.39
-3.48 (-2.51%)
May 29, 2026, 4:00 PM EDT - Market closed
ICU Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,157 | 2,231 | 2,382 | 2,259 | 2,280 | 1,316 | |
Revenue Growth (YoY) | -10.88% | -6.33% | 5.44% | -0.92% | 73.21% | 3.56% |
Cost of Revenue | 1,339 | 1,409 | 1,557 | 1,519 | 1,582 | 824.82 |
Gross Profit | 818.16 | 822.04 | 824.78 | 739.87 | 697.76 | 491.49 |
Selling, General & Admin | 622.54 | 625.21 | 638.76 | 606.69 | 608.35 | 302.58 |
Research & Development | 85.48 | 87.5 | 88.62 | 85.34 | 92.98 | 47.5 |
Other Operating Expenses | 66.61 | 66.51 | 54.44 | 25.01 | 39.33 | 18.16 |
Total Operating Expenses | 774.64 | 779.21 | 781.82 | 717.05 | 740.66 | 368.25 |
Operating Income | 43.52 | 42.83 | 42.96 | 22.83 | -42.9 | 123.25 |
Total Non-Operating Income (Expense) | -34.03 | -39.66 | -108.98 | -101.12 | -71.51 | -0.06 |
Pretax Income | 11.29 | 4.36 | -66.01 | -78.3 | -114.41 | 123.19 |
Provision for Income Taxes | -36.85 | 2.44 | 51.68 | -48.64 | -40.12 | 20.05 |
Net Income | 31.94 | 1.92 | -117.69 | -29.66 | -74.29 | 103.14 |
Net Income to Common | 31.94 | 1.92 | -117.69 | -29.66 | -74.29 | 103.14 |
Net Income Growth | - | - | - | - | - | 18.72% |
Shares Outstanding (Basic) | 25 | 25 | 24 | 24 | 24 | 21 |
Shares Outstanding (Diluted) | 25 | 25 | 24 | 24 | 24 | 22 |
Shares Change (YoY) | 1.43% | 2.12% | 1.23% | 0.93% | 9.58% | 0.88% |
EPS (Basic) | 1.87 | 0.03 | -4.83 | -1.23 | -3.11 | 4.86 |
EPS (Diluted) | 1.85 | 0.03 | -4.83 | -1.23 | -3.11 | 4.74 |
EPS Growth | - | - | - | - | - | 17.91% |
Shares Outstanding | 24.99 | 24.69 | 24.52 | 24.14 | 23.99 | 21.28 |
Free Cash Flow | 82.71 | 91.8 | 124.66 | 82.31 | -152.44 | 199 |
Free Cash Flow Growth | -9.91% | -26.36% | 51.46% | - | - | 52.20% |
Free Cash Flow Per Share | 3.33 | 3.69 | 5.11 | 3.42 | -6.39 | 9.14 |
Gross Margin | 37.93% | 36.84% | 34.62% | 32.75% | 30.60% | 37.34% |
Operating Margin | 2.02% | 1.92% | 1.80% | 1.01% | -1.88% | 9.36% |
Profit Margin | 2.23% | 0.09% | -4.94% | -1.31% | -3.26% | 7.84% |
FCF Margin | 3.83% | 4.11% | 5.23% | 3.64% | -6.69% | 15.12% |
EBITDA | 244.84 | 243.57 | 262.48 | 251.6 | 192.25 | 212.94 |
EBITDA Margin | 11.35% | 10.92% | 11.02% | 11.14% | 8.43% | 16.18% |
EBIT | 43.52 | 42.83 | 42.96 | 22.83 | -42.9 | 123.25 |
EBIT Margin | 2.02% | 1.92% | 1.80% | 1.01% | -1.88% | 9.36% |
Effective Tax Rate | -326.40% | 55.92% | -78.28% | 62.13% | 35.07% | 16.28% |